Medpace Holdings, Inc. Files 8-K for Material Agreement

TL;DR

Medpace just signed a big deal, filing an 8-K. Keep an eye on this.

AI Summary

On March 28, 2024, Medpace Holdings, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this event. The company is incorporated in Delaware and headquartered in Cincinnati, Ohio.

Why It Matters

This filing indicates a significant new agreement for Medpace Holdings, Inc., which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.

Key Players & Entities

• Medpace Holdings, Inc. (company) — Registrant
• March 28, 2024 (date) — Date of earliest event reported
• 5375 Medpace Way, Cincinnati, Ohio 45227 (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — hange on which registered Common Stock $0.01 par value MEDP NASDAQ Global Select Mar
• $10 million — the facility's line of credit to up to $10 million and extends the expiration date of the

Filing Documents

• medp-20240328.htm (8-K) — 27KB
• medp-20240329xexx101.htm (EX-10.1) — 189KB
• 0001668397-24-000066.txt ( ) — 370KB
• medp-20240328.xsd (EX-101.SCH) — 2KB
• medp-20240328_lab.xml (EX-101.LAB) — 21KB
• medp-20240328_pre.xml (EX-101.PRE) — 12KB
• medp-20240328_htm.xml (XML) — 3KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On March 28, 2024, Medpace Holdings, Inc., a Delaware corporation (the "Company"), through its wholly owned subsidiaries, Medpace, Inc., as borrower, and Medpace IntermediateCo, Inc., as guarantor, entered into Amendment No. 6 to Loan Documents ("Amendment No. 6") with PNC Bank, National Association in connection with the Company's unsecured credit facility (the "Loan Documents"). Amendment No. 6 changes the aggregate principal amount that may be borrowed under the facility's line of credit to up to $10 million and extends the expiration date of the revolving credit note to March 31, 2025. The foregoing description of Amendment No. 6 is qualified in its entirety by reference to Amendment No. 6. A copy of Amendment No. 6 is filed herewith as Exhibit 10.1 and incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Amendment No. 6 dated March 28 , 202 4 to Loan Documents 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MEDPACE HOLDINGS, INC. Date: March 29, 2024 By: /s/ Stephen P. Ewald Stephen P. Ewald General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR